Zobrazeno 1 - 10
of 204
pro vyhledávání: '"Luka, Brcic"'
Autor:
Teresa Sassmann, Philipp Douschan, Vasile Foris, Natascha Tröster, Katarina Zeder, Luka Brcic, Adrienn Tornyos, Gerhard Bachmaier, Michael Fuchsjäger, Horst Olschewski, Gabor Kovacs
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background Pulmonary hypertension (PH) is a frequent complication in COPD and it is associated with decreased exercise capacity and poor prognosis. We hypothesized that even in COPD patients without significant PH at rest, abnormal pulmonary
Externí odkaz:
https://doaj.org/article/714192d0a4f34031b2fd0d93de53f2cc
Autor:
Tanja Grossmann, Andrijana Kirsch, Magdalena Grill, Barbara Steffan, Michael Karbiener, Luka Brcic, Barbara Darnhofer, Ruth Birner-Gruenberger, Markus Gugatschka
Publikováno v:
PLoS ONE, Vol 18, Iss 6, p e0287634 (2023)
Research of human vocal fold (VF) biology is hampered by several factors. The sensitive microstructure of the VF mucosa is one of them and limits the in vivo research, as biopsies carry a very high risk of scarring. A laryngeal organotypic model cons
Externí odkaz:
https://doaj.org/article/56223399c4ed4c67b895946bcdd28a1c
Autor:
Arailym Sarsembayeva, Melanie Kienzl, Eva Gruden, Dusica Ristic, Kathrin Maitz, Paulina Valadez-Cosmes, Ana Santiso, Carina Hasenoehrl, Luka Brcic, Jörg Lindenmann, Julia Kargl, Rudolf Schicho
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
Cannabinoid (CB) receptors (CB1 and CB2) are expressed on cancer cells and their expression influences carcinogenesis in various tumor entities. Cells of the tumor microenvironment (TME) also express CB receptors, however, their role in tumor develop
Externí odkaz:
https://doaj.org/article/8fc695dd4a07458a91b2e4e48bd4b41a
Autor:
Simon Strohmeier, Iva Brcic, Helmut Popper, Bernadette Liegl-Atzwanger, Jörg Lindenmann, Luka Brcic
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract In the last two decades, various therapies have been introduced for lung carcinoma patients, including tyrosine-kinase inhibitors for different mutations. While some of them are specific to specific tumor types, others, like NTRK1–3 fusion
Externí odkaz:
https://doaj.org/article/a1931cd4b02e42c9bec476b343ff09ed
Autor:
Elisabeth Smolle, Petra Leko, Elvira Stacher‐Priehse, Luka Brcic, Amin El‐Heliebi, Lilli Hofmann, Franz Quehenberger, Andelko Hrzenjak, Helmut H. Popper, Horst Olschewski, Katharina Leithner
Publikováno v:
Molecular Oncology, Vol 14, Iss 11, Pp 2853-2867 (2020)
Inhibition of glycolysis has been considered as a therapeutic approach in aggressive cancers including lung cancer. Abbreviated gluconeogenesis, mediated by phosphoenolpyruvate carboxykinase (PEPCK), was recently discovered to partially circumvent th
Externí odkaz:
https://doaj.org/article/a2f2a16a21f04888bfde536c4d65ec87
Autor:
Paulina Valadez-Cosmes, Kathrin Maitz, Oliver Kindler, Sofia Raftopoulou, Melanie Kienzl, Ana Santiso, Zala Nikita Mihalic, Luka Brcic, Jörg Lindenmann, Melanie Fediuk, Martin Pichler, Rudolf Schicho, A. McGarry Houghton, Akos Heinemann, Julia Kargl
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Neutrophils have been described as a phenotypically heterogeneous cell type that possess both pro- and anti-tumor properties. Recently, a subset of neutrophils isolated from the peripheral blood mononuclear cell (PBMC) fraction has been described in
Externí odkaz:
https://doaj.org/article/34db15e98bdf4ffb9ebb9e98f6bef13e
Autor:
Helmut Popper, Luka Brcic
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Large cell neuroendocrine carcinoma (LCNEC) together with small cell carcinoma (SCLC) and typical and atypical carcinoids form the group of pulmonary neuroendocrine tumors. LCNEC and SCLC are high-grade carcinomas. Although both can be found outside
Externí odkaz:
https://doaj.org/article/bd18dc4ec02a4590984dcc97c7b63bc1
Autor:
Luka Brcic, Christian Kuchler, Sylvia Eidenhammer, Daniela Pabst, Franz Quehenberger, Adi F. Gazdar, Helmut Popper
Publikováno v:
Diagnostic Pathology, Vol 14, Iss 1, Pp 1-9 (2019)
Abstract Background Small cell lung cancer (SCLC) is usually diagnosed in the advanced stage. It has a very poor prognosis, with no advancements in therapy in the last few decades. A recent phase 1 clinical study, using an antibody-drug conjugate dir
Externí odkaz:
https://doaj.org/article/9ee65802d0e544c5a1394a0ec0244c3a
Publikováno v:
Radiation Oncology, Vol 14, Iss 1, Pp 1-11 (2019)
Abstract Background Despite the advances in oncology, patients with bulky tumors have worse prognosis and often receive only palliative treatments. Bulky disease represents an important challenging obstacle for all currently available radical treatme
Externí odkaz:
https://doaj.org/article/82722ab24edf40469ac72f314976039c
Autor:
Martina Baněčková, Lester D.R. Thompson, Martin D. Hyrcza, Tomáš Vaněček, Abbas Agaimy, Jan Laco, Roderick H.W. Simpson, Silvana Di Palma, Todd M. Stevens, Luka Brcic, Arghavan Etebarian, Katarina Dimnik, Hanna Majewska, Ivo Stárek, Esther O’Regan, Tiziana Salviato, Tim Helliwell, Markéta Horáková, Wojciech Biernat, Timothy Onyuma, Michal Michal, Ilmo Leivo, Alena Skalova
Publikováno v:
American Journal of Surgical Pathology. 47:661-677
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a05c9c826e0bba3cb6313d8bd5ac08c
https://doi.org/10.1097/pas.0000000000002043
https://doi.org/10.1097/pas.0000000000002043